upadacitinib
-
Morphic’s stock prices soar by 75%! Eli Lilly invests an additional $3.2 billion in the autoimmune field
DrugTimes will present more reports timely. Please stay tuned
-
艾伯维公布Rinvoq的最新数据，Rinvoq能否顺利接棒Humira？
原文始发于微信公众号（药时代）：艾伯维公布Rinvoq的最新数据，Rinvoq能否顺利接棒Humira？ 谈及艾伯维，不可避免的会想到“药王”Humira。这款蝉联8年药王宝座的药…
